(Q50978189)

26 March 2018

title

Role of oral contraceptives in the growth of a multilobular adenoma associated with a hepatocellular carcinoma in a young woman. (English)

1 reference

26 March 2018

main subject

hepatocellular carcinoma

1 reference

Perret AG

1

1 reference

26 March 2018

Mosnier JF

2

1 reference

26 March 2018

Porcheron J

3

1 reference

26 March 2018

Cuilleron M

4

1 reference

26 March 2018

Berthoux P

5

1 reference

26 March 2018

Boucheron S

6

1 reference

26 March 2018

Audigier JC

7

1 reference

26 March 2018

publication date

1 December 1996

1 reference

26 March 2018

published in

Journal of Hepatology

1 reference

26 March 2018

volume

25

1 reference

26 March 2018

issue

6

1 reference

26 March 2018

page(s)

976-979

1 reference

26 March 2018

Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Hepatocellular carcinoma and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Cancer of the liver and the use of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Oral contraceptive use and liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Female hormone utilisation and risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Liver adenomatosis. An entity distinct from liver adenoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Possible association between benign hepatomas and oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Liver-Cell Adenomas Associated with Use of Oral Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Regression of liver cell adenomas associated with oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Cyproterone acetate induces DNA damage in cultured rat hepatocytes and preferentially stimulates DNA synthesis in gamma-glutamyltranspeptidase-positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Liver tumours in women on oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

The steroid receptor superfamily: more excitement predicted for the future

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Hepatocellular carcinoma arising in a focus of multilobular adenoma. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980305-9

7 January 2021

10.1016/S0168-8278(96)80305-9

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018